Showing 7231-7240 of 20895 results for "".
- Delgocitinib Clinical Trials Data Publishedhttps://reachmd.com/news/delgocitinib-clinical-trials-data-published/2467444/LEO Pharma A/S announced that the findings of the DELTA 1 and DELTA 2 phase 3 clinical trials for delgocitinib cream have been published in the peer-reviewed periodical The Lancet. This is the first time The Lancet has published data on an investigational topical pan-Janus kinase (JAK) inhibitor
- Stress-Related Cell Damage Linked to Negative Mental and Physical Health Effects Among Caregivershttps://reachmd.com/news/stress-related-cell-damage-linked-to-negative-mental-and-physical-health-effects-among-caregivers/2467435/It’s no secret that the caregivers of spouses with memory impairment face enormous amounts of stress. Researchers at Rice University have found that this intense pressure can be felt at the cellular level and is linked to negative physical and ment
- HIV Clinical Guidelines Now Recommend High Resolution Anoscopy as Part of Anal Cancer Screening Program for People with HIVhttps://reachmd.com/news/hiv-clinical-guidelines-now-recommend-high-resolution-anoscopy-as-part-of-anal-cancer-screening-program-for-people-with-hiv/2467414/A panel of experts in HIV care has released new recommendations to prevent anal cancer for people with HIV, the first U.S. federal guidelines on the topic. These recommendations include a screening program that uses high resolution anoscopy (HRA) to help detect and treat precancer and p
- Psilocybin Generates Psychedelic Experience by Disrupting Brain Networkhttps://reachmd.com/news/psilocybin-generates-psychedelic-experience-by-disrupting-brain-network/2467438/Visit the News Hub Psilocybin generates psychedelic experience by disrupting brain networkStudy advances efforts to harness drug's mind-altering power to treat mental illnessSara
- Surgical Method Developed in Leipzig for the Treatment of Cervical Cancer Offers Advantages Over Standard Treatmenthttps://reachmd.com/news/surgical-method-developed-in-leipzig-for-the-treatment-of-cervical-cancer-offers-advantages-over-standard-treatment/2467405/Cervical cancer is the fourth most common malignant tumour in women worldwide. In the early stages, surgery can be of benefit to most patients. In a comparative study including more than 1000 patients with more than 10 years of follow-up, the standard treatment for this cancer has now
- ADI-270 Gains FDA Fast Track Status in Metastatic/Advanced ccRCChttps://reachmd.com/news/adi-270-gains-fda-fast-track-status-in-metastaticadvanced-ccrcc/2467343/A fast track designation has been given to ADI-270 from the FDA for treating metastatic or advanced clear cell renal cell carcinoma (ccRCC) previously treated with an immune checkpoint inhibitor and a VEGF inhibitor.ADI-270 is an allogeneic, off-th
- Analyzing CAVI as a Prognostic Factor for Cardiovascular and Kidney Outcomeshttps://reachmd.com/news/analyzing-cavi-as-a-prognostic-factor-for-cardiovascular-and-kidney-outcomes/2467396/The following is a summary of “Prognostic Value of Cardio-Ankle Vascular Index for Cardiovascular and Kidney Outcomes: Systematic Review and Meta-Analysis,” published in the issue of Cardiology by Tavolinejad et al. Stiff
- Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosishttps://reachmd.com/news/ultrasonography-of-hepatocellular-carcinoma-from-diagnosis-to-prognosis/2467413/by Xia & He Publishing Inc.
- Hypertension Disorders of Pregnancy Largely Persist in the Postpartum Periodhttps://reachmd.com/news/hypertension-disorders-of-pregnancy-largely-persist-in-the-postpartum-period/2467393/A cohort study of 2705 patients found that 81.8% of individuals with hypertensive disorders of pregnancy (HDP; preeclampsia or gestational hypertension) had ongoing hypertension after hospital discharge, wi
- Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2https://reachmd.com/news/make-way-at-last-for-the-third-mitraclip-rct-in-functional-mr-reshape-hf-2/2467404/In the list of “hot line” trials just released by the European Society of Cardiology (ESC) for its upcoming congress is one that many cardiologists may have all but forgotten they’d been waiting for. RES